Courtney DiNardo
MD, MSCE
Professor, Department of Leukemia
👥Biography 个人简介
Courtney DiNardo has been at the forefront of developing venetoclax-based regimens for AML, leading the VIALE-A trial that established venetoclax plus azacitidine as a standard of care for older or unfit AML patients. Her work on IDH inhibitor combinations and resistance mechanisms has shaped current treatment paradigms. She has authored seminal publications defining optimal sequencing of targeted therapies in AML.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Courtney DiNardo 的研究动态
Follow Courtney DiNardo's research updates
留下邮箱，当我们发布与 Courtney DiNardo（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment